NCT07114913 Symptom Distribution and Pain Sensitization in Carpal Tunnel Syndrome
| NCT ID | NCT07114913 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Sultan Abdulhamid Han Training and Research Hospital, Istanbul, Turkey |
| Condition | Carpal Tunnel Syndrome |
| Study Type | OBSERVATIONAL |
| Enrollment | 80 participants |
| Start Date | 2025-06-21 |
| Primary Completion | 2026-01-01 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 80 participants in total. It began in 2025-06-21 with a primary completion date of 2026-01-01.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
This study aims to compare central sensitization parameters between carpal tunnel syndrome (CTS) patients with extra median symptom distribution and those with typical, median nerve-related symptoms. Extra median sensory spread, observed in some CTS patients beyond the anatomical boundaries of the median nerve, may reflect central sensitization mechanisms. Using the Central Sensitization Inventory and pressure pain threshold measurements, this study will assess whether extra median symptom patterns are associated with increased central sensitization.
Eligibility Criteria
Inclusion Criteria: * Having been diagnosed with carpal tunnel syndrome based on clinical and electrodiagnostic findings * Being between 18 and 65 years of age * Being literate * Agreeing to participate in the study Exclusion Criteria: * Having a history of concomitant diabetes, systemic inflammatory disease, active infection, or malignancy * Being \<18 and \>65 years of age * Being illiterate * Refusing to participate in the study * Having a disease associated with neuropathic pain, such as polyneuropathy, radiculopathy, or multiple sclerosis * History of injection or surgery for CTS within the last 6 months
Contact & Investigator
Emre Ata
STUDY CHAIR
Saglik Bilimleri Universitesi
Frequently Asked Questions
Who can join the NCT07114913 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, up to 65 Years, studying Carpal Tunnel Syndrome. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT07114913 currently recruiting?
Yes, NCT07114913 is actively recruiting participants. Contact the research team at dr.fny28@gamil.com for enrollment information.
Where is the NCT07114913 trial being conducted?
This trial is being conducted at Istanbul, Turkey (Türkiye).
Who is sponsoring the NCT07114913 clinical trial?
NCT07114913 is sponsored by Sultan Abdulhamid Han Training and Research Hospital, Istanbul, Turkey. The principal investigator is Emre Ata at Saglik Bilimleri Universitesi. The trial plans to enroll 80 participants.